<DOC>
	<DOCNO>NCT01989988</DOCNO>
	<brief_summary>The investigator would like conduct randomize clinical trial compare efficacy diabetes treatment different gastric bypass procedure involve type 2 diabetic patient BMI 27.5 35 kg/m2</brief_summary>
	<brief_title>DMBSS-A Randomized Trial Different Laparoscopic Gastric Bypass Surgery Patients With Obesity-related T2DM</brief_title>
	<detailed_description>The investigator would like conduct randomize clinical trial compare efficacy diabetes treatment different gastric bypass procedure involve type 2 diabetic patient BMI 27.5 35 kg/m2 . This program determine relative effectiveness among LMGB 、RYGB SADJB .The primary end point include HbA1C &lt; 6.0 % , LDL-C &lt; 100mg/dl SBP &lt; 130mmHg one year surgery . Through study , investigator may understand gastric bypass best type 2 diabetic 's treatment . The investigator also hope new treatment modulation may develop .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Age 20 67 year Diagnosed T2DM least 6 month prior enrollment , active care doctor least six month prior enrollment , HbA1c ≥ 7.5 % Body Mass Index ( BMI ) ≥ 27.5 kg/m 2 ≤ 34.9 kg/m 2 Willingness accept random assignment either treatment group . Willingness comply followup protocol Written inform consent . Cardiovascular event ( myocardial infarction , acute coronary syndrome , coronary artery angioplasty bypass , stroke ) past six month . Current evidence congestive heart failure , angina pectoris , symptomatic peripheral vascular disease . Cardiac stress test indicating surgery would safe . Pulmonary embolus thrombophlebitis past six month Cancer kind ( except basal cell skin cancer cancer situ ) unless document diseasefree five year Serum creatinine ≥ 1.5 mg/dl History stomach surgery , bile duct surgery , pancreatic surgery , splenectomy , colon resection Previous organ transplantation . History alcohol drug dependency Current participation conflict research protocol .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>67 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Type 2 Diabetes Mellitus ( T2DM )</keyword>
	<keyword>Obesity</keyword>
	<keyword>Laparoscopic gastric bypass</keyword>
	<keyword>Duodenum exclusion</keyword>
</DOC>